acetylcysteine has been researched along with Down Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ashida, A; Ikenaka, A; Kazuki, Y; Li, L; Nakahata, T; Nishinaka-Arai, Y; Niwa, A; Russell, DW; Saito, MK; Tamai, H; Toshikawa, H | 1 |
Behar, TN; Colton, CA | 1 |
Jóźwiak, Z; Kania, K; Zych, A | 1 |
3 other study(ies) available for acetylcysteine and Down Syndrome
Article | Year |
---|---|
N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21.
Topics: Acetylcysteine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Antioxidants; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Down Syndrome; Down-Regulation; Humans; Induced Pluripotent Stem Cells; Nerve Tissue Proteins; Neurons; Oxidative Stress | 2021 |
Redox regulation of neuronal migration in a Down Syndrome model.
Topics: Acetylcysteine; Animals; Chemotaxis; Disease Models, Animal; Dithiothreitol; Down Syndrome; Fetus; Glutamic Acid; Mice; N-Methylaspartate; Neurons; Oxidation-Reduction; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Trisomy | 2003 |
Involvement of reactive oxygen species in aclarubicin-induced death of human trisomic and diabetic fibroblasts.
Topics: Acetylcysteine; Aclarubicin; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Calcium; Cell Line; Diabetes Mellitus, Type 2; Down Syndrome; Fibroblasts; Humans; Membrane Potential, Mitochondrial; Necrosis; Pyrrolidines; Reactive Oxygen Species; Thiocarbamates | 2007 |